Business Description
Nanalysis Scientific Corp
NAICS : 334511
SIC : 3912
ISIN : CA63000Y1034
Share Class Description:
NSCIF: Ordinary SharesTotal Employee Number:
107Compare
Compare
Traded in other countries / regions
NSCI.CanadaNSCIF.USA1N1.Germany IPO Date
2020-01-07Description
Nanalysis Scientific Corp has two primary operating segments. Its first operating segment, Scientific Equipment, conducts scientific equipment manufacturing and sales, mainly as a patent-protected technology company that develops, manufactures, and sells magnetic resonance products for education, pharmaceutical, biotech, nutraceutical, chemical, food, materials, security, life science, and medical applications. Its second operating segment, Security Services, focuses on providing preventative and on-call maintenance services, as well as installation of detection and analysis equipment. The majority of this segment consists of servicing a Crown Corporation of the Government of Canada, maintaining imaging and security equipment at international airports across Canada.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | -16.78 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.01 | |||||
Beneish M-Score | -3.05 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.3 | |||||
3-Year EBITDA Growth Rate | 50.3 | |||||
3-Year EPS without NRI Growth Rate | 21.7 | |||||
3-Year Book Growth Rate | -35.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.48 | |||||
9-Day RSI | 25.25 | |||||
14-Day RSI | 29.21 | |||||
3-1 Month Momentum % | 17.65 | |||||
6-1 Month Momentum % | -11.3 | |||||
12-1 Month Momentum % | -43.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.02 | |||||
Quick Ratio | 0.75 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 49.27 | |||||
Days Sales Outstanding | 68.25 | |||||
Days Payable | 61.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.9 | |||||
Shareholder Yield % | 0.79 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 23.99 | |||||
Operating Margin % | -8.9 | |||||
Net Margin % | -14.01 | |||||
EBITDA Margin % | -2.2 | |||||
FCF Margin % | -2.18 | |||||
OCF Margin % | 1.56 | |||||
ROE % | -43.66 | |||||
ROA % | -15.09 | |||||
ROIC % | -10.61 | |||||
3-Year ROIIC % | -21.09 | |||||
ROC (Joel Greenblatt) % | -46.61 | |||||
ROCE % | -20.75 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 2.83 | |||||
PS Ratio | 0.36 | |||||
PB Ratio | 1.28 | |||||
Price-to-Operating-Cash-Flow | 24 | |||||
EV-to-EBIT | -7.19 | |||||
EV-to-EBITDA | -34.71 | |||||
EV-to-Revenue | 0.76 | |||||
EV-to-Forward-Revenue | 0.87 | |||||
EV-to-FCF | -35.76 | |||||
Price-to-GF-Value | 0.38 | |||||
Earnings Yield (Greenblatt) % | -13.91 | |||||
FCF Yield % | -5.18 |
Nanalysis Scientific Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanalysis Scientific Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guru Commentaries on OTCPK:NSCIF
No articles.
Press Release
Articles on Nanalysis Scientific Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers